Cargando…

Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis

BACKGROUND: To date, no guideline is proposed for elderly nasopharyngeal carcinoma (NPC) due to lack of prospective clinical trials. The present study comparing the survivals and toxicities in elderly NPC patients received either induction chemotherapy followed by radiotherapy(IC + RT) or concurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qi, Wang, Jie, Lv, Xing, Li, Jie, Yin, Li-Jie, Xiang, Yan-Qun, Guo, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004294/
https://www.ncbi.nlm.nih.gov/pubmed/27577729
http://dx.doi.org/10.1186/s12885-016-2661-y
_version_ 1782450776794202112
author Zeng, Qi
Wang, Jie
Lv, Xing
Li, Jie
Yin, Li-Jie
Xiang, Yan-Qun
Guo, Xiang
author_facet Zeng, Qi
Wang, Jie
Lv, Xing
Li, Jie
Yin, Li-Jie
Xiang, Yan-Qun
Guo, Xiang
author_sort Zeng, Qi
collection PubMed
description BACKGROUND: To date, no guideline is proposed for elderly nasopharyngeal carcinoma (NPC) due to lack of prospective clinical trials. The present study comparing the survivals and toxicities in elderly NPC patients received either induction chemotherapy followed by radiotherapy(IC + RT) or concurrent chemoradiotherapy (CCRT) was therefore undertaken to provide a more accurate basis for future clinical practice. METHODS: The eligible elderly NPC patients were retrospectively enrolled. Propensity score matching generated a matched cohort (1:2) composed from CCRT and IC + RT groups. The survivals and treatment-induced toxicities were compared between two groups. Multivariable analysis was carried to identify significant prognostic factors. RESULTS: The 5-year overall survival, cancer-specific survival, locoregional failure-free survival, distant failure-free survival for all patients were 58.3 %, 62.7 %, 88.7 %, 83.0 %, respectively. No significant survival differences were found between CCRT and IC + RT groups in the propensity-matched cohort. In comparison with the patients who received IC + RT, patients who underwent CCRT were associated with more severe acute toxicities including leucopenia (30 % vs. 6.8 %, P = 0.005), anemia (20 % vs. 4.1 %, P = 0.027), mucositis (63.3 % vs. 34.2 %, P = 0.007), weight loss (23.4 % vs. 4.1 %, P = 0.009). Basicranial bone involvement was an independent prognostic factor that predicted all-cause death (HR = 0.553, 95 % CI 0.329–0.929; P = 0.025) and cancer specific death (HR = 0.558, 95 % CI 0.321–0.969; P = 0.038) in elderly patients. CONCLUSIONS: In the context of no guideline for elderly NPC, the present study suggested IC + RT should be a preferable modality compared with CCRT, with similar treatment outcomes but less acute toxicities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2661-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5004294
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50042942016-08-31 Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis Zeng, Qi Wang, Jie Lv, Xing Li, Jie Yin, Li-Jie Xiang, Yan-Qun Guo, Xiang BMC Cancer Research Article BACKGROUND: To date, no guideline is proposed for elderly nasopharyngeal carcinoma (NPC) due to lack of prospective clinical trials. The present study comparing the survivals and toxicities in elderly NPC patients received either induction chemotherapy followed by radiotherapy(IC + RT) or concurrent chemoradiotherapy (CCRT) was therefore undertaken to provide a more accurate basis for future clinical practice. METHODS: The eligible elderly NPC patients were retrospectively enrolled. Propensity score matching generated a matched cohort (1:2) composed from CCRT and IC + RT groups. The survivals and treatment-induced toxicities were compared between two groups. Multivariable analysis was carried to identify significant prognostic factors. RESULTS: The 5-year overall survival, cancer-specific survival, locoregional failure-free survival, distant failure-free survival for all patients were 58.3 %, 62.7 %, 88.7 %, 83.0 %, respectively. No significant survival differences were found between CCRT and IC + RT groups in the propensity-matched cohort. In comparison with the patients who received IC + RT, patients who underwent CCRT were associated with more severe acute toxicities including leucopenia (30 % vs. 6.8 %, P = 0.005), anemia (20 % vs. 4.1 %, P = 0.027), mucositis (63.3 % vs. 34.2 %, P = 0.007), weight loss (23.4 % vs. 4.1 %, P = 0.009). Basicranial bone involvement was an independent prognostic factor that predicted all-cause death (HR = 0.553, 95 % CI 0.329–0.929; P = 0.025) and cancer specific death (HR = 0.558, 95 % CI 0.321–0.969; P = 0.038) in elderly patients. CONCLUSIONS: In the context of no guideline for elderly NPC, the present study suggested IC + RT should be a preferable modality compared with CCRT, with similar treatment outcomes but less acute toxicities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2661-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-30 /pmc/articles/PMC5004294/ /pubmed/27577729 http://dx.doi.org/10.1186/s12885-016-2661-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zeng, Qi
Wang, Jie
Lv, Xing
Li, Jie
Yin, Li-Jie
Xiang, Yan-Qun
Guo, Xiang
Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
title Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
title_full Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
title_fullStr Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
title_full_unstemmed Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
title_short Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
title_sort induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004294/
https://www.ncbi.nlm.nih.gov/pubmed/27577729
http://dx.doi.org/10.1186/s12885-016-2661-y
work_keys_str_mv AT zengqi inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis
AT wangjie inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis
AT lvxing inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis
AT lijie inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis
AT yinlijie inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis
AT xiangyanqun inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis
AT guoxiang inductionchemotherapyfollowedbyradiotherapyversusconcurrentchemoradiotherapyinelderlypatientswithnasopharyngealcarcinomafindingfromapropensitymatchedanalysis